Scopolamine-Induced Amnesia Model

The brain's cholinergic system is implicated in cognitive processes. Scopolamine, a muscarinic cholinergic receptor antagonist, impairs learning and memory in both rodents and humans. Charles River conducts contract studies in established scopolamine-induced amnesia models in rodents to facilitate research and the development of compounds for Alzheimer's and other diseases with negative impact on memory and cognitive functions.

In mice, the cognitive tests used are contextual fear conditioning (CFC) and social transmission of food preference (STFP), both acknowledged as memory tests requiring hippocampal functions. In rats, we use the passive avoidance test and T-maze alternation learning.

You may also be interested in...

In Vitro Alzheimer's Disease Model

Charles River conducts contract studies in an established in vitro model of Alzheimer’s disease to assess the efficacy of novel compounds

Biomarker Services

We can support your drug discovery pipeline by providing biomarker analysis in a non-GxP environment.